• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纽约州新发终末期肾病患者的心脏死亡率分析。

An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State.

作者信息

Wallen M D, Radhakrishnan J, Appel G, Hodgson M E, Pablos-Mendez A

机构信息

Division of Epidemiology, Columbia University School of Public Health, New York, NY, USA.

出版信息

Clin Nephrol. 2001 Feb;55(2):101-8.

PMID:11269672
Abstract

End-stage renal disease (ESRD) is associated with an overall one-year mortality of 23.5% in the US, of which cardiac causes constitute 50% of all deaths. Data on incident ESRD patients were obtained from the Health Care Financing Administration's 2728 and 2746 forms by special request from the ESRD Network of New York. 4,948 ESRD patients, who started dialysis in New York State from April 1, 1995, through April 1, 1996, were assessed to identify risk factors present at the initiation of dialysis that predict cardiac death. 899 deaths were registered during the 19-month-follow-up period, 50% of which were from cardiac causes. Using the Cox-proportional hazards model, the increasing age category, white race, the presence of one or more vascular co-morbid conditions, and the presence of diabetes and one or more cardiac co-morbid conditions significantly predicted cardiac death (p < 0.05). Diabetes increased the risk for cardiac death by 48% for those patients without any cardiac co-morbidities (RR = 1.48, p < 0.0082). In contrast with results observed in the general population, gender, serum albumin and body mass index were not significant predictors of cardiac death. In identifying risk factors present at the initiation ofdialysis that predict cardiac death, this study highlights factors that may be modified prior to dialysis initiation in order to improve life expectancy and mortality rates and decrease health care costs for the ESRD population.

摘要

在美国,终末期肾病(ESRD)患者的总体一年死亡率为23.5%,其中心脏病因导致的死亡占所有死亡人数的50%。终末期肾病新发病例患者的数据是应纽约终末期肾病网络的特别要求,从医疗保健财务管理局的2728表和2746表中获取的。对1995年4月1日至1996年4月1日在纽约州开始透析的4948例终末期肾病患者进行评估,以确定透析开始时存在的可预测心脏死亡的危险因素。在19个月的随访期内记录了899例死亡病例,其中50%是由心脏病因导致的。使用Cox比例风险模型,年龄增长、白人种族、存在一种或多种血管合并症、患有糖尿病以及存在一种或多种心脏合并症显著预测了心脏死亡(p<0.05)。对于没有任何心脏合并症的患者,糖尿病使心脏死亡风险增加了48%(风险比=1.48,p<0.0082)。与普通人群中观察到的结果相反,性别、血清白蛋白和体重指数并不是心脏死亡的显著预测因素。在确定透析开始时存在的可预测心脏死亡的危险因素时,本研究强调了在透析开始前可能加以改变的因素,以便提高预期寿命和降低死亡率,并降低终末期肾病患者的医疗保健成本。

相似文献

1
An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State.纽约州新发终末期肾病患者的心脏死亡率分析。
Clin Nephrol. 2001 Feb;55(2):101-8.
2
The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients.透析开始时合并存在的风险因素对终末期肾病患者生存的影响。
ASAIO J. 1996 May-Jun;42(3):164-9.
3
[Predictors of early death during dialysis].[透析期间早期死亡的预测因素]
Nefrologia. 2001 May-Jun;21(3):274-82.
4
Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients.新发透析患者非致死性心肌梗死和心源性死亡的危险因素
Nephrol Dial Transplant. 2009 Jan;24(1):258-66. doi: 10.1093/ndt/gfn426. Epub 2008 Aug 5.
5
Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.糖尿病终末期肾病的肾脏替代治疗。突尼斯一家医院中心的经验。
Diabetes Metab. 2001 Nov;27(5 Pt 1):584-90.
6
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.血清白蛋白、C反应蛋白、白细胞介素6和胎球蛋白A作为终末期肾病患者营养不良、心血管疾病及死亡率的预测指标。
Am J Kidney Dis. 2006 Jan;47(1):139-48. doi: 10.1053/j.ajkd.2005.09.014.
7
Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).透析预后与实践模式研究(DOPPS)中美国新入组血液透析患者早期死亡的预测因素。
Clin J Am Soc Nephrol. 2007 Jan;2(1):89-99. doi: 10.2215/CJN.01170905. Epub 2006 Nov 29.
8
Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions.合并症患病率较低的长期血液透析患者的死亡预测因素
Nephrol Dial Transplant. 1995;10(9):1708-13.
9
Duration of end-stage renal disease and kidney transplant outcome.终末期肾病的病程与肾移植结果。
Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16.
10
Thrombotic microangiopathy in United States long-term dialysis patients.美国长期透析患者的血栓性微血管病
Nephrol Dial Transplant. 2006 Jan;21(1):191-6. doi: 10.1093/ndt/gfi153. Epub 2005 Oct 4.

引用本文的文献

1
Heart Failure and Worsening Renal Function: Prevalence, Risk Factors, and Impact on Hospital Readmissions in an Urban Minority Population.心力衰竭与肾功能恶化:城市少数民族人群中的患病率、危险因素及其对再次入院的影响
J Clin Med. 2025 Jan 28;14(3):877. doi: 10.3390/jcm14030877.
2
Health-Related Quality of Life in End-Stage Renal Disease Patients and Healthy Individuals.终末期肾病患者与健康个体的健康相关生活质量
Galen Med J. 2020 Dec 29;9:e1987. doi: 10.31661/gmj.v9i0.1987. eCollection 2020.
3
The impact of hemodialysis on mortality risk and cause of death in Staphylococcus aureus endocarditis.
血液透析对金黄色葡萄球菌性心内膜炎患者死亡风险及死因的影响。
BMC Nephrol. 2018 Sep 3;19(1):216. doi: 10.1186/s12882-018-1016-0.
4
Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients.韩国新发病血液透析患者中Charlson合并症指数的重新校准与验证
PLoS One. 2015 May 18;10(5):e0127240. doi: 10.1371/journal.pone.0127240. eCollection 2015.
5
Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients.与终末期肾病(ESRD)患者使用导管相比,使用动静脉内瘘与较低的心血管死亡率相关。
Semin Dial. 2008 Sep-Oct;21(5):483-9. doi: 10.1111/j.1525-139X.2008.00467.x. Epub 2008 Aug 29.